Physician profile
Lisa Smith
NPI 1427425081
$936.82
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $459 · 2022: $219 · 2023: $188 · 2024: $70.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $259.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $258.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $196.30 | 2021-2024 | Xtampza, Belbuca |
| Boston Scientific Corporation | $101.41 | 2021-2022 | |
| Radius Health, INC. | $87.50 | 2021-2022 | |
| Biodelivery Sciences International, INC. | $78.61 | 2021 | |
| Abbott Laboratories | $74.63 | 2021-2022 | |
| Amgen INC. | $69.51 | 2021-2023 | Evenity, Prolia |
| Arbor Pharmaceuticals, INC. | $58.49 | 2021-2022 | |
| Scilex Pharmaceuticals INC. | $56.84 | 2021 | |
| Grt US Holding, INC. | $53.75 | 2021-2022 | |
| Almatica Pharma LLC | $45.52 | 2021 | |
| Azurity Pharmaceuticals, INC. | $39.16 | 2023 | Horizant |
| Spinal Simplicity, LLC | $22.15 | 2024 | Ha Minuteman G3-R |
| Vertos Medical, INC. | $22.03 | 2023 | Mild Device Kit |
| Convatec INC. | $16.42 | 2024 | |
| Horizon Therapeutics Plc | $14.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.